NHS North of England Branded Medicines Tranche A & Annual Tranche

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£1
Sector
HEALTH
Published
15 Mar 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points

Geochart for 1 buyers and 37 suppliers

1 buyer

29 suppliers

Description

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.Offer reference number: CM/PHR/20/5606CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 monthsCM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months

Lot Division

1 CM/PHR/20/5606/01 - NHS Framework for North of England Branded - Tranche A

Lot 1 - CM/PHR/20/5606/01 … Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
2 CM/PHR/20/5606/02 - NHS Framework for North of England Branded - Annual Tranche

CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
3 CM/PHR/20/5606/03 - NHS Supply of Risankizumab for South of England & London

Lot 3 - CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Award Detail

1 Roche Products (Welwyn Garden City)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-1
  • Value: £1
2 Sandoz (Surrey)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-2
  • Value: £1
3 Teva (Castleford)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-3
  • Value: £1
4 Chugai Pharma (London)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-4
  • Value: £1
5 Amgen (Cambridge)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-5
  • Value: £1
6 Janssen Cilag (Highwycombe)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-6
  • Value: £1
7 Accord (Devon)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-7
  • Value: £1
8 Pfizer (Kent)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-8
  • Value: £1
9 Abbvie (Berks)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-9
  • Value: £1
10 Ipsen (Slough)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-10
  • Value: £1
11 Pharmacosmos (Berkshire)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-11
  • Value: £1
12 Merck Serono (Middlesex)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-12
  • Value: £1
13 Novo Nordisk (Gatwick)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-13
  • Value: £1
14 Merz (Hemel Hempstead)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-14
  • Value: £1
15 Vifor Pharma (London)
  • Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A
  • Reference: 007498-2023-15
  • Value: £1
16 Roche Products (Welwyn Garden City)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-16
  • Value: £1
17 Teva (Castleford)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-17
  • Value: £1
18 Celltrion Healthcare (Slough)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-18
  • Value: £1
19 Merck Sharpe & Dohme (London)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-19
  • Value: £1
20 Amgen (Cambridge)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-20
  • Value: £1
21 Janssen Cilag (Highwycombe)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-21
  • Value: £1
22 Accord (Devon)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-22
  • Value: £1
23 Pfizer (Kent)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-23
  • Value: £1
24 Thornton & Ross (Huddersfield)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-24
  • Value: £1
25 Glaxosmithkline (London)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-25
  • Value: £1
26 Abbvie (Berks)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-26
  • Value: £1
27 Aventis Pharma (Berkshire)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-27
  • Value: £1
28 Astrazeneca (London)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-28
  • Value: £1
29 Takeda (London)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-29
  • Value: £1
30 Organon Pharmaceuticals (London)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-30
  • Value: £1
31 Zentiva Pharma (London)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-31
  • Value: £1
32 Eli Lilly (Hants)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-32
  • Value: £1
33 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-33
  • Value: £1
34 Gedeon Richter (London)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-34
  • Value: £1
35 Almirall (Uxbridge)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-35
  • Value: £1
36 Ucb Pharma (Berkshire)
  • Lot 2 - CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche
  • Reference: 007498-2023-36
  • Value: £1
37 Abbvie (Berks)
  • Lot 3 - CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London
  • Reference: 007498-2023-37
  • Value: £1

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains